| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 192.05M | 212.88M | 218.00M | 168.82M | 175.41M | 77.22M |
| Gross Profit | 110.18M | 138.19M | 137.99M | 116.51M | 124.06M | 13.91M |
| EBITDA | 97.34M | 123.89M | 126.73M | 106.32M | 119.94M | 8.51M |
| Net Income | 93.11M | 119.42M | 123.38M | 105.48M | 119.81M | 8.28M |
Balance Sheet | ||||||
| Total Assets | 2.72B | 2.63B | 2.47B | 2.59B | 2.57B | 2.60B |
| Cash, Cash Equivalents and Short-Term Investments | 67.04M | 53.52M | 49.40M | 59.78M | 117.42M | 54.68M |
| Total Debt | 1.50B | 1.39B | 1.26B | 1.39B | 1.41B | 1.46B |
| Total Liabilities | 1.59B | 1.49B | 1.34B | 1.48B | 1.47B | 1.54B |
| Stockholders Equity | 1.13B | 1.14B | 1.14B | 1.12B | 1.10B | 1.07B |
Cash Flow | ||||||
| Free Cash Flow | 87.80M | 112.58M | 125.87M | 114.21M | 54.49M | 75.94M |
| Operating Cash Flow | 87.80M | 112.58M | 125.87M | 114.21M | 54.49M | 75.94M |
| Investing Cash Flow | -105.41M | -139.68M | 93.40M | -431.04M | 211.06M | 13.48M |
| Financing Cash Flow | 42.88M | 14.25M | -231.43M | 238.33M | -138.63M | -76.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $816.68M | 9.07 | 9.07% | 10.80% | -6.30% | -6.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $854.13M | 12.69 | 5.43% | 14.17% | 36.15% | -38.59% | |
66 Neutral | $1.06B | 8.15 | 8.75% | 17.34% | -16.58% | 65.24% | |
62 Neutral | $888.05M | 9.52 | 8.18% | 13.18% | -26.08% | -27.65% | |
60 Neutral | $851.29M | 24.61 | 3.44% | 13.64% | 36.91% | -48.79% | |
60 Neutral | $859.53M | 10.25 | 7.03% | 13.63% | -8.23% | -35.72% |
On January 29, 2026, Bain Capital Specialty Finance, Inc. entered into a Fourth Supplemental Indenture with U.S. Bank Trust Company, National Association, covering the issuance of $350 million in 5.950% notes due March 1, 2031, which were sold in a registered offering that closed the same day. The notes, general unsecured obligations ranking senior to subordinated debt and pari passu with other unsecured unsubordinated obligations, carry semi-annual interest payments starting September 1, 2026, include change-of-control repurchase protections and Investment Company Act-related asset coverage covenants, and generated approximately $342.5 million in net proceeds that the company plans to use to repay outstanding secured indebtedness under its financing arrangements and for general corporate purposes, effectively extending its debt maturity profile and shifting its capital structure toward more unsecured funding.
The most recent analyst rating on (BCSF) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.
On January 22, 2026, Bain Capital Specialty Finance, Inc. entered into an underwriting agreement with BCSF Advisors, LP and a syndicate of underwriters led by Wells Fargo Securities, J.P. Morgan Securities, and SMBC Nikko Securities America to issue and sell $350 million of 5.950% notes due 2031. The transaction, conducted under the company’s existing shelf registration, adds a sizable tranche of long-dated, fixed-rate debt to its capital structure, reinforcing its funding base and potentially supporting future lending activity, while customary indemnification and covenant provisions align with standard market practice and help manage legal and underwriting risks for all parties involved.
The most recent analyst rating on (BCSF) stock is a Buy with a $15.50 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.
On December 22, 2025, Bain Capital Specialty Finance, Inc. announced that its board had declared a special cash dividend of $0.15 per share, to be paid on January 26, 2026, to shareholders of record as of December 31, 2025. The company said the special distribution, driven by over-earnings during the year, is intended to help manage its tax and regulated investment company distribution requirements, while supporting disciplined capital management and maintaining spillover income to underpin the stability of its regular dividend and the gradual growth of net asset value per share over time.
The most recent analyst rating on (BCSF) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.
On November 10, 2025, Bain Capital Specialty Finance announced its financial results for the third quarter ending September 30, 2025, and declared a fourth quarter dividend of $0.42 per share, along with an additional $0.03 per share dividend previously announced. The company reported strong earnings driven by high net investment income, which exceeded their regular dividend, and maintained healthy credit performance. The announcement reflects Bain Capital Specialty Finance’s robust operational performance and strategic positioning in the middle-market lending space, potentially benefiting stakeholders with continued high-quality investment opportunities.
The most recent analyst rating on (BCSF) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.
On November 5, 2025, Bain Capital Specialty Finance appointed Sabrina Rusnak-Carlson as General Counsel. Her extensive experience in credit and public equity law, along with her previous roles at First Eagle Alternative Credit and Proskauer Rose LLP, positions her to significantly contribute to the company’s legal and strategic operations.
The most recent analyst rating on (BCSF) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.